PCSK9 Inhibitors

What are PCSK9 Inhibitors? The Food and Drug Administration recently approved two products in a new class of cholesterol-lowering drugs known as PCSK9 Inhibitors. This class of drugs reduces the amount of low-density lipoprotein cholesterol (LDL-C), or “bad... read more

DRUG NEWS: Daraprim®

In the News: Daraprim® Turing Pharmaceuticals, the company who recently bought the rights to Daraprim® (pyrimethamine), implemented a massive price increase for the drug this past month, claiming that it had been severely under-priced for years. Costs in the U.S. for... read more

First Biosimilar Medication Earns U.S. FDA Approval

On March 6, 2015, Zarxio™ (filgrastim-sndz), which is manufactured by Sandoz, was the first biosimilar medication to receive approval by the U.S. Food and Drug Administration (FDA). Zarxio is biosimilar to Neupogen®, which is manufactured by Amgen. However, these two... read more